Dual-funnel model: Pet somatic cell cryo Diagram

Strengths

• Low-threshold annual fees for front-end customer screening, locking in future high-ticket potential clients
• Extremely high unit price for cloning delivery with significant gross margin per order
• First-mover advantage in successful cases and reputation building a brand barrier

Weaknesses

• Long delivery cycle of 6-10 months for cloning, with heavy asset investment pressure
• High costs for technology promotion and ethical communication
• Uncertain conversion rate from front-end cryopreservation to back-end cloning

Opportunities

• Approaching peak aging of pets in China, rapidly expanding the demand pool
• New growth opportunities from overseas Chinese and pet owners in Southeast Asia, Japan, and South Korea
• Potential for stacking value-added services like gene-edited life extension

Threats

• Risk of tightening ethical policies on animal cloning and negative public opinion
• Late-coming competitors diluting unit prices
• Negative publicity regarding health issues or short lifespans of clones could shatter industry trust